We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXPE:NASDAQExpedia Group, Inc. Analysis

Data as of 2026-05-21 - not real-time

$214.12

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Expedia Group (EXPE) trades around $214, far below its DCF‑derived fair value of roughly $694, implying a potential upside of more than 200% despite a bearish technical backdrop – RSI sits at 34, the MACD is in a bearish crossover, and the price is under the 20‑, 50‑ and 200‑day moving averages, hovering just above the identified support of $206. Recent headlines highlight weak full‑year guidance and a drop in bookings outlook, which have pressured the stock despite the company posting solid earnings.
On the fundamentals side, EXPE delivered $15.2 B of revenue with 14.7% YoY growth, maintains an impressive 90% gross margin and a 7% operating margin, and generated $3.48 B of free cash flow. The balance sheet is net‑cash positive (cash $5.79 B vs debt $4.71 B), supports a sustainable dividend (0.81% yield, 14.8% payout), and forward EPS forecasts suggest earnings more than double the trailing figure. The recent acquisition of CarTrawler signals a strategic push to strengthen its B2B platform, reinforcing a longer‑run growth narrative.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Weak full‑year guidance and earnings disappointment
  • Bearish technical indicators (RSI, MACD, below SMA levels)
  • High short‑term volatility and proximity to support

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong cash generation and net‑cash position
  • Strategic B2B expansion via CarTrawler acquisition
  • Forward earnings growth and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Robust revenue growth and high gross margins
  • Continued balance‑sheet strength and dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth14.70%
Profit Margin9.81%
P/E Ratio18.9
ROE71.49%
ROA5.83%
Debt/Equity256.54
P/B Ratio44.6
Op. Cash Flow$4.9B
Free Cash Flow$3.5B

Technical Analysis

TrendBearish
RSI34.8
Support$206.35
Resistance$257.35
MA 20$233.56
MA 50$237.41
MA 200$238.52
MACDBearish
VolumeIncreasing
Fear & Greed Index90.48

Valuation

Fair Value$693.55
Target Price$286.32
Upside/Downside33.72%
GradeUndervalued
TypeGrowth
Dividend Yield0.81%

Risk Assessment

Beta1.34
Volatility48.20%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.